Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02244918 · ClinicalTrials.gov registry record · Phase 4
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
A Phase 4 study of Smoking Cessation, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 278
- Enrollment target
- 2
- Study locations
NCT02244918: Completed Phase 4 study of Smoking Cessation, sponsored by University of Kansas Medical Center.
NCT02244918 is a Phase 4 study of Smoking Cessation that has completed, run by University of Kansas Medical Center. The registered enrollment target is 278 participants, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (41% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02244918, a Phase 4 study of Smoking Cessation, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 278 participants
- Enrollment target
- 2
- Study locations
Study Summary
The researchers are testing if counseling alone or counseling plus over-the-counter nicotine replacement therapies (NRT), like the patch,gum, or lozenge, helps African American non-daily smokers quit smoking.
Primary Outcome
Biochemically confirmed 30-day point prevalence abstinence at Week 12 using urine anabasine and anatabine, with the recommended cut-off of 2 ng/ml to differentiate smokers from non-smokers.
Conditions Studied
Interventions
- BEHAVIORAL Smoking Cessation Counseling
- DRUG Nicotine Replacement Therapy
Study Locations (2)
Kansas
- University of Kansas Medical Center - Kansas City
Missouri
- Swope Health Central - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-03-15 |
| Phase | Phase 4 |
What the finished NCT02244918 record still lists
NCT02244918 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, below the 473-participant average among 188 other Smoking Cessation trials with a reported enrollment target (41% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Smoking Cessation Counseling is the first listed.
NCT02244918 reports a single indexed study location in Kansas, Missouri.
Frequently Asked Questions
What is clinical trial NCT02244918 about?
NCT02244918 is a clinical study titled "Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers". The researchers are testing if counseling alone or counseling plus over-the-counter nicotine replacement therapies (NRT), like the patch,gum, or lozenge, helps African American non-daily smokers quit smoking.
What is the current status of trial NCT02244918?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 278 participants. The study started on 2015-05. Estimated completion is 2018-03-15.
What conditions does trial NCT02244918 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT02244918?
The interventions under investigation include: Smoking Cessation Counseling (BEHAVIORAL), Nicotine Replacement Therapy (DRUG).
Who is sponsoring clinical trial NCT02244918?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02244918 being conducted?
This trial has 2 study locations across Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02244918's enrollment target sits among peer trials
278 87th of 188 higher than 102 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia